GALT Next Earnings Date Notes

— Galectin Therapeutics (ticker: GALT) is a clinical-stage biotechnology company focused on developing therapies for fibrotic diseases & cancer, with its lead product candidate, belapectin, targeting nonalcoholic steatohepatitis (NASH) with advanced fibrosis/cirrhosis. The company's approach leverages its expertise in galectin biology – specifically, inhibiting galectin-3, a protein linked to fibrosis & inflammation. For investors, the most critical business metrics to follow include updates from GALT’s ongoing Phase 2b/3 NAVIGATE trial for belapectin in patients with NASH cirrhosis without esophageal varices, as positive clinical trial data would materially de-risk the path to regulatory approval – a crucial milestone for long-term success. Furthermore, monitoring the company’s cash runway, quarterly R&D spending, and partnership/licensing activity is essential, as these factors impact GALT’s ability to fund its clinical programs through pivotal readouts. On upcoming earnings calls, focus on management’s commentary around clinical trial timelines & interim results, regulatory strategy, and efforts to secure partnerships or additional financing. These will provide key insight into GALT’s progress and potential to ultimately bring its NASH therapy to market. The next projected earnings date for GALT is 11/13/2026 8:00 am (stay tuned for a confirmed earnings date once announced).

GALT Next Earnings Date FAQ

On this page we presented the GALT Next Earnings Date information for Galectin Therapeutics along with recent past earnings dates. For Q2 of 2026, GALT reported earnings of -0.140/share, with the earnings report taking place on 8/14/2026. For Q1 of 2026, GALT reported earnings of -0.080/share, with the earnings report taking place on 5/15/2026. For Q4 of 2025, GALT reported earnings of -0.080/share, with the earnings report taking place on 3/31/2026. For Q3 of 2025, GALT reported earnings of -0.130/share, with the earnings report taking place on 11/14/2025. For Q2 of 2025, GALT reported earnings of -0.120/share, with the earnings report taking place on 8/14/2025. Based on these past earnings dates, the projected next earnings date for GALT is 11/13/2026 8:00 am.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Galectin Therapeutics. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Galectin Therapeutics shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Galectin Therapeutics next earnings dates as well as any other stock out there in our coverage universe, to see when the next GALT earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up GALT's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the GALT next earnings date.